11 Patents
- US125952782026Biaryl Amides with Modified Sugar Groups for Treatment of Diseases Associated with Heat Shock Protein Pathway
REATA PHARMACEUTICALS, Inc
0 cites - US125457012026C4-modified Oleanolic Acid Derivatives for Inhibition of IL-17 and Other Uses
REATA PHARMACEUTICALS, Inc.
0 cites - US123588662025Antioxidant Inflammation Modulators: Oleanolic Acid Derivatives with Amino and Other Modifications at C-17
REATA PHARMACEUTICALS HOLDINGS, LLC
0 cites - US123446312025C17 Polar-substituted Heteroaromatic Synthetic Triterpenoids and Methods of Use Thereof
REATA PHARMACEUTICALS, Inc.
0 cites - US121954432025Pyrimidine Tricyclic Enone Derivatives for Inhibition of Ror-gamma and Other Uses
REATA PHARMACEUTICALS, Inc.
0 cites - US120603402024Cysteine-dependent Inverse Agonists of Nuclear Receptors Ror-gamma/ror-gamma-t and Methods of Treating Diseases or Disorders Therewith
REATA PHARMACEUTICALS, Inc
0 cites - US119935742024Pyrazole and Imidazole Compounds for Inhibition of IL-17 and Rorgamma
REATA PHARMACEUTICALS, Inc
0 cites - US119198382024Antioxidant Inflammation Modulators: Oleanolic Acid Derivatives with Amino and Other Modifications at C-17
REATA PHARMACEUTICALS HOLDINGS, LLC
0 cites - US118276642023Biaryl Amides with Modified Sugar Groups for Treatment of Diseases Associated with Heat Shock Protein Pathway
REATA PHARMACEUTICALS, Inc
0 cites - US118143382023Pyrazolyl and Pyrimidinyl Tricyclic Enones as Antioxidant Inflammation Modulators
REATA PHARMACEUTICALS, Inc.
0 cites - US115847752023C4-modified Oleanolic Acid Derivatives for Inhibition of IL-17 and Other Uses
REATA PHARMACEUTICALS, Inc.
0 cites